RAP2B

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RAP2B mutation is significantly associated with the RNA expression of many other genes, with 3,181 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible RAP2B-associated genes across cancer lineages are CCL4, CCL3, and SLAMF8. Each is linked with RAP2B in more than 2 cancer types. Because this analysis shows association rather than direction, both RAP2B-to-partner and partner-to-RAP2B results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CCL4 grouped by RAP2B-low versus RAP2B-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RAP2B→partner) and Y-score (partner→RAP2B) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECCCL4 →+0.926+2.454<.001<.00133
UCECCCL3 →+0.864+1.617<.001.00333
UCECSLAMF8 →+0.821+2.103<.001.00333
UCECCCL7 →+0.520+2.115<.001<.00133
UCECMMP12 →+1.575+2.684<.001<.00133
UCECRN7SL134P →+0.102+2.014<.001.00133
Each partner links to its Q-omics profile. Showing the 6 strongest of 3,181 associations by consensus.

CCL4 by RAP2B expression — UCEC

Box plot of CCL4 in RAP2B-low vs RAP2B-high samples in UCEC.

Explore this box plot interactively →

Exploration